NuCana plc (NASDAQ: NCNA) Stock Information | RedChip

NuCana plc (NASDAQ: NCNA) Listen to this Section


$3.31
+0.0200 ( +0.61% ) 21.7K

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.

Market Data


Open


$3.31

Previous close


$3.29

Volume


21.7K

Market cap


$7.86M

Day range


$3.15 - $3.49

52 week range


$2.53 - $20.26

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
6-k Quarterly Reports 51 Aug 15, 2024
6-k Quarterly Reports 1 Jun 18, 2024
6-k Quarterly Reports 4 May 16, 2024
6-k Quarterly Reports 28 May 13, 2024
6-k Quarterly Reports 2 May 01, 2024
6-k Quarterly Reports 2 Apr 16, 2024
6-k Quarterly Reports 2 Apr 09, 2024
6-k Quarterly Reports 2 Mar 27, 2024
6-k Quarterly Reports 2 Mar 20, 2024
20-f Annual reports 117 Mar 20, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.